| 3’-UTR | 3’-untranslated region |
| ALP | alkaline phosphatase |
| BMP | bone morphogenetic protein |
| CAC | coronary artery calcification |
| CKD | chronic kidney disease |
| DM | diabetes mellitus |
| DNMT | DNA methyltransferase |
| ESRD | end-stage renal disease |
| GSK | glycogen synthase kinase |
| HDAC | histone deacetylase |
| HMT | histone methyltransferase |
| HP | high phosphate |
| IGF | insulin-like growth factor |
| IS | indoxyl sulfate |
| KLF | Kruppel-like factor |
| LDLR | low density lipoprotein receptor |
| lncRNA | long non-coding RNA |
| MBD | methyl-CpG binding domain |
| Mecp | methyl-CpG binding protein |
| miRNA | microRNA |
| MSC | mesenchymal stem cell |
| mTOR | mammalian target of rapamycin |
| MV | matrix vesicle |
| NFAT | nuclear factor of activated T cells |
| NF-κB | nuclear factor-κB |
| PPAR-γ | peroxisome proliferator-activated receptor-γ |
| PRMT | protein arginine N-methyltransferase |
| PTEN | phosphatase and tensin homolog |
| qPCR | quantitative polymerase chain reaction |
| RUNX2 | Runt-related transcription factor 2 |
| SATB | special AT-rich sequence-binding protein |
| SIRT | sirtuin |
| SMA | smooth muscle actin |
| TGF | transforming growth factor |
| VC | vascular calcification |
| VSMC | vascular smooth muscle cell |